Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Preclinical Investigation of Ultra-High Drug-Loaded Hydrogels for Improving Glaucoma Surgery Outcomes
Author Affiliations & Notes
  • Malik Salman Haider
    Augenklinik und Poliklinik, Universitatsklinikum Wurzburg, Wuerzburg, Bayern, Germany
  • Raoul Verma-Fuehring
    Augenklinik und Poliklinik, Universitatsklinikum Wurzburg, Wuerzburg, Bayern, Germany
  • Jeanette Weigelt
    Department for Functional Materials in Medicine and Dentistry and Bavarian Polymer Institute, Julius-Maximilians-Universitat Wurzburg, Wurzburg, Bayern, Germany
  • Jörg Teßmar
    Department for Functional Materials in Medicine and Dentistry and Bavarian Polymer Institute, Julius-Maximilians-Universitat Wurzburg, Wurzburg, Bayern, Germany
  • Daniel Kampik
    Augenklinik und Poliklinik, Universitatsklinikum Wurzburg, Wuerzburg, Bayern, Germany
  • Jost Hillenkamp
    Augenklinik und Poliklinik, Universitatsklinikum Wurzburg, Wuerzburg, Bayern, Germany
  • Footnotes
    Commercial Relationships   Malik Salman Haider None; Raoul Verma-Fuehring None; Jeanette Weigelt None; Jörg Teßmar None; Daniel Kampik None; Jost Hillenkamp None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 1924. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Malik Salman Haider, Raoul Verma-Fuehring, Jeanette Weigelt, Jörg Teßmar, Daniel Kampik, Jost Hillenkamp; Preclinical Investigation of Ultra-High Drug-Loaded Hydrogels for Improving Glaucoma Surgery Outcomes. Invest. Ophthalmol. Vis. Sci. 2024;65(7):1924.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Filtration surgery is primary treatment for advanced glaucoma, but its success is limited by fibrosis. To enhance the success rate, we aim to develop a novel hydrogel that is safe and patient-friendly. It can serve as an adjunct during surgery, preventing fibrosis and reducing the need for repeat surgeries.

Methods : Poly-2-oxazolines (POx)-based ABA triblock copolymers were synthesized as reported earlier. Cytocompatibility was assessed by XTT assay on primary cells. Micelles were prepared via liquid dispersion method with various polymer-to-dexamethasone (DEX) ratios. Drug loading was determined by UV-Vis spectroscopy and size analysis by dynamic light scattering. Micelles were visualized through negative staining and cryo-scanning electron microscopy. The hydrogel was prepared using an acrylate-based derivative of hyaluronic acid (HAA). Along with photo-initiators within the visible light spectrum, it can be set to hydrogel in under 60 seconds. The stability studies (hours to weeks) of the micellar formulation were conducted. The hydrogel was also tested to demonstrate that cells could not adhere to it (FDA and Hoechst staining). The bioadhesive nature of the hydrogel was investigated on porcine sclera.

Results : POx-based ABA triblock copolymer showed no signs of cytotoxicity (cell viability > 95%), even at highest concentration of 50 g/L. The triblock copolymer solublized around 4.8 ± 0.18 g/L of DEX (loading capacity 30 wt.% and loading efficiency 80%). The micelle size was 20-30 nm and appeared spherical. The HAA showed a porous morphology under cryo-SEM. The HAA hydrogel non-cell adhesive property was studied, revealing the creation of an interface between cells and the hydrogel surface. The HAA hydrogel is injectable and exhibited fast crosslinking, making its use ideal for applications in fast-gelling hydrogel systems at the surgical site. This is demonstrated by employing the hydrogels on the defect on the porcine sclera followed by crosslinking. The bioadhesive nature was confirmed under a stream of water.

Conclusions : We have demonstrated HAA-based hydrogels loaded with DEX-POx micelles. These hydrogels are non-cell adhesive but offer bio-adhesiveness during crosslinking. They can potentially be used as an adjunct in glaucoma filtration surgery. However, this warrants further detailed preclinical investigation.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×